VivoSeq
Other

Allograft

0

Pipeline Programs↗

5

Active Trials↗

2

Companies Involved↗

Allograft is an early-stage landscape with 0 programs across 2 companies. The most active players are Pfizer, Astellas.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

25/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalAstellas logo

Astellas

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

28

clinical trials

Completed14 · 50%
Terminated4 · 14%
Withdrawn3 · 11%
Active, not recruiting3 · 11%
Recruiting2 · 7%
Unknown status2 · 7%

Clinical Trials

Trial Activity

28 trials

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain
Recruiting·RR3 Stem Cell·Phase 1·NCT06361485·100 enrolled
Chronic Lung Allograft Dysfunction MRI Study
Recruiting·—·Phase 1/2·NCT06406777·100 enrolled
Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension
Active, not recruiting·OOdense University Hospital·Phase 4·NCT06933355·8 enrolled
Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities
Active, not recruiting·AAmnio Technology, LLC·Phase 2·NCT04667416·82 enrolled
Study of Drug Acceptance and Its Persistence Over Time in Patients Receiving a Haematopoietic Stem Cell Allograft: a Pilot Study at the University Hospital of Limoges
Active, not recruiting·UUniversity Hospital, Limoges·Preclinical·NCT05164835·20 enrolled
The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates
Completed·MMayo Clinic·Phase 2·NCT00722722·18 enrolled
Belatacept Therapy for the Failing Renal Allograft
Completed·—·Phase 3·NCT01921218·13 enrolled
ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)
Completed·—·Phase 4·NCT00140907·367 enrolled
Evaluation of Amnion Chorion Membrane and Demineralized Bone Matrix Putty Allograft in Periodontal Intrabony Defects
Completed·—·N/A·NCT02679209·22 enrolled
Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant
Completed·TTBF Genie Tissulaire·Phase 1·NCT05236049·12 enrolled
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Completed·Astellas logoAstellas·Phase 3·NCT00933231·281 enrolled
Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction
Completed·—·Phase 4·NCT02597543·14 enrolled
Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)
Completed·Pfizer logoPfizer·N/A·NCT00697112·53 enrolled
Optima: Optimizing Prograf Therapy in Maintenance Allografts II
Completed·—·Phase 4·NCT00905515·63 enrolled
The Role of B Cells in Kidney Allograft Dysfunction
Completed·LLoma Linda University·N/A·NCT02294032·180 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)